NewsRx

Search our medical news database

Cyberonics, Inc.

Medicare outpatient reimbursement rates for 2006 for VNS therapy posted

Published in Medicine and Law Weekly, December 9th, 2005

Cyberonics, Inc., (CYBX) announced that 2006 Medicare outpatient reimbursement rates for Cyberonics' VNS Therapy System have been posted on the CMS website.

Beginning January 2006, average Medicare reimbursement to hospitals for outpatient implantation of the VNS Therapy System increases 8.6% to $26,649 for the implantation and intra-operative programming of the VNS Therapy Systems as follows: $11,603 under APC 0039 for implantation of neurostimulator, $14,928 under APC 0225 for implantation of neurostimulator electrodes, and $118 under APC 0692 for the intra-operative electrode test.

"Cyberonics is very pleased with Medicare's decision to once again...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medicine and Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook